Defense sector stocks surged after a study revealed an estimated $26 billion in munitions were used by the US and allied forces in the first 16 days of the Middle East war, signaling a revenue boom for arms manufacturers.
The report, published by the UK's Royal United Services Institute, detailed the expenditure, which included over 11,200 missiles and interceptor munitions, underscoring the intensity of the initial conflict phase.
Fueling the rally, the US State Department has approved $16.5 billion in foreign military sales to Gulf nations since the war's start. The primary beneficiaries of these contracts are expected to be Raytheon, Lockheed Martin, and Northrop Grumman, the Pentagon's largest suppliers.
The massive outlay on munitions and subsequent state-approved sales provide a clear and substantial revenue pipeline for top-tier defense firms. Investors are pricing in sustained top-line growth as geopolitical tensions translate directly into multi-billion dollar order books, likely leading to a broader re-rating of the entire defense sector.
This article is for informational purposes only and does not constitute investment advice.